Source:http://linkedlifedata.com/resource/pubmed/id/17405926
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2007-4-4
|
pubmed:abstractText |
In the central nervous system (CNS), neuregulin-1 (NRG-1) proteins function in neuronal migration, differentiation, and survival of oligodendrocytes. The NRG-1 gene codes for at least 15 different isoforms, which may be classified on the basis of their molecular structure. At least two different haplotypes of the NRG-1 gene may be associated with schizophrenia. An abnormal expression pattern of NRG-1 mRNA was found in the prefrontal cortex of schizophrenic patients in comparison to controls. We here show that the NRG-1alpha isoform is significantly reduced in white matter of the prefrontal cortex in schizophrenia but not in affective disorder. In the prefrontal gray matter, the density of NRG-1alpha expressing neurons was reduced in individuals with schizophrenia and in unipolar patients. We studied brains of 22 schizophrenics, 12 patients with affective disorders (7 unipolar and 5 bipolar), and 22 matched controls. NRG-1alpha immunoreactive material was detected with a polyclonal antiserum against the synthetic peptide from alpha-type EGF-like domain of human NRG. The demonstrated decreased number of NRG-1 immunoreactive neurons in the brains of schizophrenics and patients with unipolar depression points to an important role of this NRG-1alpha splice variant in neuropsychiatric disorders. Reduced NRG-1alpha protein concentrations were found in brains of schizophrenics after Western blot analysis. The diminished expression of NRG-1alpha strongly supports an early neurodevelopmental component to schizophrenia.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0077-8923
|
pubmed:author |
pubmed-author:BernsteinHans-GertHG,
pubmed-author:BertramIrisI,
pubmed-author:BielauHendrikH,
pubmed-author:BogertsBernhardB,
pubmed-author:BukowskaAlicjaA,
pubmed-author:DobrowolnyHenrikH,
pubmed-author:FalkaiPeterP,
pubmed-author:KanakisDimitriosD,
pubmed-author:KeilhoffGerburgG,
pubmed-author:LendeckelUweU,
pubmed-author:MawrinChristianC
|
pubmed:issnType |
Print
|
pubmed:volume |
1096
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
147-56
|
pubmed:meshHeading |
pubmed-meshheading:17405926-Adult,
pubmed-meshheading:17405926-Cell Movement,
pubmed-meshheading:17405926-Depressive Disorder,
pubmed-meshheading:17405926-Female,
pubmed-meshheading:17405926-Gene Expression Regulation,
pubmed-meshheading:17405926-Humans,
pubmed-meshheading:17405926-Immunohistochemistry,
pubmed-meshheading:17405926-Male,
pubmed-meshheading:17405926-Middle Aged,
pubmed-meshheading:17405926-Neuregulin-1,
pubmed-meshheading:17405926-Prefrontal Cortex,
pubmed-meshheading:17405926-Schizophrenia,
pubmed-meshheading:17405926-Signal Transduction
|
pubmed:year |
2007
|
pubmed:articleTitle |
Immunohistochemical evidence for impaired neuregulin-1 signaling in the prefrontal cortex in schizophrenia and in unipolar depression.
|
pubmed:affiliation |
Exp. Psychiatry Lab., University of Magdeburg, Leipziger Str. 44, D-39120 Magdeburg, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|